Stockreport

PainReform Provides Year-End Business Update

PainReform Ltd. - Ordinary Shares  (PRFX) 
PDF Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce top-line data by mid-2024 TEL AVIV, Israel, [Read more]